Ventilator Associated Pneumonia Clinical Trial
Official title:
The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe Pneumonia
The purpose of the study is to determine if the clinical course of pneumonia is more severe when both, bacterial and viral pathogens are find as possible causative agent and how does it affect treatment.
Basic demographic data of the patients (age, gender), data on concomitant diseases and
epidemiological circumstances will be collected
Severity of illness will be assessed by APACHE II (at day 1) and SOFA (at day 1,2,3 and 7)
scoring system
Following laboratory tests will be performed at day 1, 2,3 and 7.:
- blood count analysis
- differential blood count
- C- reactive protein, procalcitonin
- glucose, urea, potassium, sodium, chloride, magnesium, creatinine, bilirubin, protein,
albumin, alkaline phosphatase, aspartate aminotransferase, alanine transaminase,
gamma-glutamyl transpeptidase , alpha-amylase, lipase, creatine kinase, lactate
dehydrogenase, myoglobin
- arterial blood gas analysis
- tests of hemostasis.
Additional 2 mL of blood will be taken at day 1 and day 21 (or later), due to paired
serologic testing
To establish the presence of potential pathogens we will perform following microbiological
investigations:
- cultivation of 2 pairs of blood cultures in all patients
- cultivation of sputum or quantitative cultivation of tracheal aspirate in nonintubated
patients
- quantitative cultivation of tracheal aspirate or bronchoalveolar lavage in intubated
patients
- testing the presence of soluble Legionella antigen in urine in all patients
- testing the presence of genetic material of respiratory viruses (influenza A, influenza
B, respiratory syncytial virus , adenovirus, bocavirus, coronavirus, metapneumovirus,
parainfluenza virus, rhinovirus) by qualitative polymerase chain reaction (PCR) in
nasopharyngeal swabs in all patients, in the tracheal aspirate in nonintubated patients
and in tracheal aspirate or bronchoalveolar lavage fluid in intubated patients
- testing the presence of mycoplasmal, legionella and chlamydial DNA by qualitative PCR
in nasopharyngeal smears in all patients, in the tracheal aspirate in nonintubated
patients and in bronchoalveolar lavage fluid or in tracheal aspirate in intubated
patients
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03937947 -
Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
|
||
Not yet recruiting |
NCT04057625 -
Transthoracic Ultrasound in the Diagnosis and Follow-up of Ventilator Associated Pneumonia
|
N/A | |
Not yet recruiting |
NCT03267693 -
Gastrointestinal Complications in Association With Oropharyngeal and Respiratory Infections in Mechanical Ventilation
|
N/A | |
Completed |
NCT02078999 -
Biomarkers in Patients Undergoing Mechanical Ventilation
|
N/A | |
Completed |
NCT00726167 -
Serum Procalcitonin Study in the Management of Ventilated Patients
|
N/A | |
Recruiting |
NCT05124977 -
Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive Care
|
N/A | |
Recruiting |
NCT05331885 -
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
|
Phase 3 | |
Completed |
NCT05517759 -
Application of VAP Bundle Among ICU Nurses
|
||
Active, not recruiting |
NCT04488510 -
Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
|
||
Completed |
NCT03917888 -
Clinical Impact of Lung Ultrasound Monitoring for Diagnosis of VAP
|
N/A | |
Not yet recruiting |
NCT06066489 -
Effect of Educational Program About Preventive Care Bundle for Prevention of Ventilator Associated Pneumonia Among Newborns
|
N/A | |
Completed |
NCT02096328 -
Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia
|
Phase 2 | |
Terminated |
NCT00771719 -
Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia
|
Phase 1 | |
Recruiting |
NCT05696093 -
Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
|
Phase 3 | |
Recruiting |
NCT05354778 -
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
|
N/A | |
Not yet recruiting |
NCT06059040 -
Effect of Eliminating Gastric Residual Volume Monitoring on Ventilator Associated Events
|
N/A | |
Completed |
NCT04563104 -
Lung Ultrasound in Procalcitonin- Guided Antibiotic Discontinuation in Ventilator Associated Pneumonia
|
||
Terminated |
NCT01975350 -
Efficacy Study of Colistimethate Sodium Inhalation in Patients With Ventilator-associated Pneumonia
|
||
Recruiting |
NCT06000761 -
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
|
N/A | |
Not yet recruiting |
NCT03294837 -
Treatment of Ventilator Associated Pneumonia in Pediatric Intensive Care Unit
|
N/A |